DNTH   $90.9  1.75% Market Open

Dianthus Therapeutics, Inc.
Total Cash 360.71M
totalCashPerShare 12.288
EBITDA -68.68M
Total Debt 407.00K
quickRatio 36.133
currentRatio 36.463
Total Revenue 4.12M
debtToEquity 0.114
Revenue/Share 0.2
ROA -0.1984
ROE -0.27331
grossProfits
freeCashflow -35.12M
operatingCashflow -51.31M
earningsGrowth
revenueGrowth 0.923
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -11.918409
profitMargins 0.0
enterpriseValue 461.91M
forwardPE -10.148551
floatShares 13.40M
sharesOutstanding 29.37M
sharesShort 4.73M
sharesShortPriorMonth 4.33M
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.09%
heldPercentInstitutions 1.02%
Short Ratio help_outline 16.99%
shortPercentOfFloat 0.23%
impliedSharesOutstanding
bookValue 12.204
Price To Book help_outline 2.30
earningsQuarterlyGrowth
netIncomeToCommon -56.68M
trailingEps -1.93%
forwardEps -2.76%
enterpriseToEbitda -6.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.59 3Q 2024
institutionsCount 116
lastUpdated Nov. 2, 2024, 6:39 a.m.